High Resolution Assessment of Minimal Residual Disease (MRD) By Next-Generation Sequencing (NGS) and High-Sensitivity Flow Cytometry (hsFCM) in the Phase 3 GAIA (CLL13) TrialMoritz Fürstenau,Anke Schilhabel,Sandra Robrecht,Can Zhang,Julia Von Tresckow,Carsten Utoft Niemann,Arnon P. Kater,Eugen Tausch,Florian Simon,Nisha De Silva,Anna-Maria Fink,Kirsten Fischer,Clemens-Martin Wendtner,Michael Gregor,Patrick Thornton,Philipp B. Staber,Tamar Tadmor,Mark-David Levin,Marinus H.J. Van Oers,Caspar Da Cunha-BangBlood（2021）引用 3|浏览14暂无评分摘要Background:更多查看译文AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
